1220.47.0032 Boehringer Ingelheim Investigational Site

Nashville, Tennessee

0 studies enrolling now · 1 studies all time

What they study most

Hepatitis C

Studies at this site

• Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-naïve Genotype 1 Hepatitis C Infected Patients (STARTverso 2) — Completed